Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 344articles · 30d
- 8+ hour agolatest article
- Aug 17, 2026earliest in window
- 92%with images
- 291avg words
- Economy, Business & Finance 196
- Health & Wellness 161
- Medical 159
- Business & Industrial 143
- Finance & Business 132
- Health 75
- Science & Technology 55
- Science & Nature 36
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
3+ day, 23+ hour ago (194+ words) BioSpace Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief…...
Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Atopic Dermatitis
5+ day, 16+ hour ago (149+ words) - Trial did not meet the primary endpoint of percent change in Eczema Area and Severity Index (EASI) score from baseline at Week 12; EVO756 was generally well tolerated - EVO301, the Company’s IL-18BP fusion protein, advances as lead atopic dermatitis program following positive Phase…...
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026
5+ day, 22+ hour ago (711+ words) BioSpace Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 The event will provide an overview of the PAM pathway, a critical signaling network that regulates cell growth, survival, and metabolism…...
Calluna Pharma Announces Participation in Upcoming Scientific and Investor Conferences
1+ week, 5+ day ago (209+ words) Company to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout European Respiratory Society (ERS) Congress 2026 Barcelona, Spain Sept. 5–9, 2026 Jonas Hallen, M.D., Ph.D. (CMO) and Toby Maher, M.D., Ph.D. (Coordinating Investigator on the AURORA study) will…...
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
1+ week, 5+ day ago (304+ words) Roche has scored a hat trick in Asia, signing a third licensing deal worth a potential $1.5 billion with a biotech there in just over a week. This time, the Swiss pharma will work with China’s Simcere Zaiming on a T…...
Orsini to Serve as Specialty Pharmacy Partner for Priovant's LISRAYA™ (brepocitinib)
2+ week, 12+ hour ago (447+ words) LISRAYA is the first FDA-approved targeted therapy for dermatomyositis. "The approval of LISRAYA represents an incredible step forward for these patients and their care journey, and Orsini is thrilled to help meaningfully improve their quality of life," Orsini CEO Brandon…...